Panacea Biotec Pharma Limited Cyclosporine Export Data — India (DGFT 2022–2026)

Name: Panacea Biotec Pharma Limited Cyclosporine Export Records India — #3 Exporter, 36 Shipments, $1.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Cyclosporine

India Pharmaceutical Trade Intelligence

$12.1M177 Suppliers100 CountriesHS 30049099

ExportsIndia → UNITED STATES26.8%India → TURKEY22.6%

ImportsFRANCE → India$28.8M UNITED STATES → India$2.0M

#1 Supplier: STRIDES PHARMA

Panacea Biotec Pharma Limited — Cyclosporine Exporter #3 | $1.7M Trade Value | TransData Nexus | TransData Nexus

Panacea Biotec Pharma Limited — Cyclosporine Exporter Profile

Indian Pharmaceutical Exporter · #3 for Cyclosporine · $1.7M export value · DGFT Verified

Panacea Biotec Pharma Limited is the #3 Indian exporter of Cyclosporine with $1.7M in export value and 36 verified shipments. Panacea Biotec Pharma Limited holds a 13.7% market share in Cyclosporine exports across 10 countries. The company exports 13 pharmaceutical products worth $23.9M across 9 therapeutic categories.

Panacea Biotec Pharma Limited — Cyclosporine Export Profile: Buyers & Destinations

Panacea Biotec Pharma Limited Cyclosporine export treemap — buyers and destination countries | TransData Nexus

Where Does Panacea Biotec Pharma Limited Export Cyclosporine?

Country	Value	Shipments	Share
ECUADOR	$124.7K	7	29.7%
MYANMAR	$93.3K	9	22.2%
TANZANIA	$52.8K	2	12.6%
PARAGUAY	$32.5K	1	7.7%
LEBANON	$30.0K	2

Who Are the Top Buyers of Cyclosporine from Panacea Biotec Pharma Limited?

Buyer	Country	Value	Orders
RIGHT & BRIGHT INTERNATIONAL COMPAN	MYANMAR	$60.2K	6
BANCO BOLIVARIANO C.A.	ECUADOR	$50.0K	1
GENERICS & SPECIALITIES LIMITED,	TANZANIA	$50.0K	1
BANCO BOLIVARIANCO CA	ECUADOR	$42.1K	2
PROSALUD FARMA S.A.	PARAGUAY	$32.5K	1
NUTRAVIT SAL (OFFSHORE)	LEBANON	$30.0K	2
SEVEN PHARMA GUATEMALA S A	GAUTEMALA	$24.8K	1
RUSBIOPHARM LLC	RUSSIA	$23.7K	2
M/S. RIGHT & BRIGHT INTERNATIONAL C	MYANMAR	$21.9K	2
BANCO BOLIVARIANO C.A. RUC 09903790	ECUADOR	$21.6K	1

Panacea Biotec Pharma Limited supplies Cyclosporine to 20 buyers globally. The largest buyer is RIGHT & BRIGHT INTERNATIONAL COMPAN (MYANMAR), followed by BANCO BOLIVARIANO C.A. (ECUADOR) and GENERICS & SPECIALITIES LIMITED, (TANZANIA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Cyclosporine Formulations Does Panacea Biotec Pharma Limited Export?

Product Description / Formulation	Value	Shipments
CYCLOSPORINE CAPSULES 100 MG (EACH SOFTGELATIN CAPSULE CONTAINS CYCLOSPORINE USP 100 MG) B/N.71623001 M/D.11/2023 E/D.1	$50.0K	1
PANIMUN BIORAL 100 MG CAPSULES (EACH SOFT GELATIN CAPSULES CONTAINS CYCLOSPORINECAPSULES 100 MG) B/N.40823003 M/D.11/20	$50.0K	1
PANIMUN BIORAL 100 MG CAPSULES (EACH SOFT GELATIN CAPSULE CONTAINS CYCLOSPORINEUSP 100 MG) B/N.306624002 M/D.11/2024 E/	$32.5K	1
PANIMUN BIORAL CAPSULES 50 MG (EACH SOFTGELATIN CAPSULE CONTAINS CYCLOSPORINE USP 50 MG) B/N.40724004 M/D.11/2024 E/D.1	$32.3K	1
PANIMUN BIORAL CAPSULES 25 MG (EACH SOFTGELATIN CAPSULE CONTAINS CYCLOSPORINE USP 25 MG) B/N.40624006, 40624007 & 40624	$26.2K	1
PANIMUN BIORAL 100 MG CAPSULES EACH SOFT GELATIN CAPSULES CONTAINS CYCLOSPORINECAPSULES 100 MG B N 302522001 M D 03 2	$24.8K	1
CYCOPORINE CAPSULES 25 MG (EACH SOFT GELATIN CAPSULE CONTAINS CYCLOSPORINE USP 25 MG) B/N.71424003 M/D.01/2025 E/D.12/20	$21.6K	1
CYCLOSPORINE CAPSULES 50 MG EACH SOFT GLEATIN CAPSULE CONTAINS CYCLOSPORINE USP50 MG B/N.71523001R M/D.07/2023 E/D.07	$21.1K	1
CYCLOSPORINE CAPSULES 50 MG EACH SOFT GELATIN CAPSULE CONTAINS CYCLOSPORINE USP50 MG B/N.71523001R M/D.07/2023 E/D.07	$21.1K	1
PANIMUN BIORAL CAPSULES 100 MG (EACH SOFT GELATIN CAPSULE CONTAINS CYCLOSPORINEUSP 100 MG) B/N.40823004 M/D.11/2023 E/D	$16.2K	3

Panacea Biotec Pharma Limited exports 28 distinct Cyclosporine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CYCLOSPORINE CAPSULES 100 MG (EACH SOFTGELATIN CAPSULE CONTA with 1 shipments worth $50.0K.

How Does Panacea Biotec Pharma Limited Compare to Nearest Cyclosporine Exporters?

Exporters ranked immediately above and below #3 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	STRIDES PHARMA SCIENCE LIMITED	$3.1M	62	2	$50.0K
3	PANACEA BIOTEC PHARMA LIMITED ★	$1.7M	36	10	$46.1K
2	CONCORD BIOTECH LIMITED	$700.0K	14	1	$50.0K
4	STARCELL BIOTECH LLP	$579.4K	21	1	$27.6K

Panacea Biotec Pharma Limited ranks #3 among 177 Indian Cyclosporine exporters. Average shipment value of $46.1K compared to the market average of $45.7K. The closest competitors by value are STRIDES PHARMA SCIENCE LIMITED and CONCORD BIOTECH LIMITED.

Which Indian Ports Ship Cyclosporine Exports?

Port	Shipments	% Share
SAHAR AIR	808	31.9%
SAHAR AIR CARGO ACC (INBOM4)	436	17.2%
DELHI AIR CARGO ACC (INDEL4)	290	11.5%
DELHI AIR	219	8.7%
Bombay Air	172	6.8%
Bombay Air Cargo	61	2.4%
Delhi Air	57	2.3%
CHENNAI AIR	52	2.1%

Geopolitical & Trade Policy Impact on Panacea Biotec Pharma Limited's Cyclosporine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Panacea Biotec. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight charges and potential delays. These maritime disruptions are particularly concerning for time-sensitive pharmaceutical shipments, as extended transit times and congestion elevate the risk of cold-chain failures for vaccines and biologics. (pharmaceuticalcommerce.com)

In the United States, recent tariff implementations have introduced uncertainties for Indian exporters. While health products have been exempt from U.S. tariffs, there is growing concern that this exemption may not be permanent. The potential imposition of tariffs on pharmaceutical imports could impact Panacea Biotec's profitability, given the company's significant export volume to the U.S. market. (lemonde.fr)

Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to capture market share previously held by Chinese manufacturers. This shift presents an opportunity for Panacea Biotec to expand its footprint in the U.S. market, provided it can navigate the evolving regulatory and trade environment effectively.

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement for exporters. The recent GMP non-compliance issue at Panacea Biotec's Baddi facility underscores the importance of adhering to stringent EU regulations. Addressing these compliance challenges promptly is essential to maintain and grow the company's presence in European markets.

Panacea Biotec Pharma Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the U.S. FDA and the European Medicines Agency (EMA) enforcing stringent quality standards. For Indian exporters, maintaining compliance with these standards is paramount to ensure uninterrupted market access.

Panacea Biotec's recent GMP non-compliance at its Baddi facility highlights the critical need for robust quality management systems. The company has committed to implementing comprehensive corrective and preventive actions and plans to request a re-inspection to reinstate its GMP certificates. (prysm.fi) Proactive measures in quality assurance will be vital for Panacea Biotec to rebuild trust with regulatory bodies and international clients.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Cyclosporine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Panacea Biotec Pharma Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 36 individual customs records matching Panacea Biotec Pharma Limited exporting Cyclosporine, covering 28 formulations to 10 countries via 20 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 100+ countries, 319+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Cyclosporine

Cyclosporine

Panacea Biotec Pharma Limited — Cyclosporine Exporter Profile

Panacea Biotec Pharma Limited — Cyclosporine Export Profile: Buyers & Destinations

Where Does Panacea Biotec Pharma Limited Export Cyclosporine?

Who Are the Top Buyers of Cyclosporine from Panacea Biotec Pharma Limited?

What Is India's Total Cyclosporine Export Value and How Much Does Panacea Biotec Pharma Limited Contribute?

What Is the Average Shipment Value for Panacea Biotec Pharma Limited's Cyclosporine Exports?

How Does Panacea Biotec Pharma Limited Compare to Other Indian Cyclosporine Exporters?

What Cyclosporine Formulations Does Panacea Biotec Pharma Limited Export?

How Does Panacea Biotec Pharma Limited Compare to Nearest Cyclosporine Exporters?

Which Indian Ports Ship Cyclosporine Exports?

What Other Immunosuppressants Products Does Panacea Biotec Pharma Limited Export?

Geopolitical & Trade Policy Impact on Panacea Biotec Pharma Limited's Cyclosporine Exports

Panacea Biotec Pharma Limited — Regulatory Compliance & Quality Standards

About Panacea Biotec Pharma Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Cyclosporine Export Data from Panacea Biotec Pharma Limited

Cyclosporine Stats

Company Overview

Top Products by Panacea Biotec Pharma Limited

Related Analysis

Need Detailed Export Data?

Data Source